Why the study?
Does omapatrilat reduce blood pressure and improve resistance artery structure and function in stroke-prone spontaneously hypertensive rats?
Population
10-week-old stroke-prone spontaneously hypertensive rats (SHRSP)
Comparison
Omapatrilat administered orally for 10 weeks vs Untreated stroke-prone spontaneously…
Design
Preclinical
Follow-up
10 weeks
Authors
Loading...
Omapatrilat improves resistance artery structure in hypertensive rats; leaves open translation to human microvascular remodeling.
Does omapatrilat reduce blood pressure and improve resistance artery structure and function in stroke-prone spontaneously hypertensive rats?
Omapatrilat potently reduces blood pressure and improves the structure and endothelial function of resistance arteries in a severe genetic model of hypertension.
Intengan et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: